Citations (74)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Kedar Khaparkhuntikar, Indrani Maji, Sunil Kumar Gupta, Srushti Mahajan, Mayur Aalhate, Anitha Sriram, Ujala Gupta, Santosh Kumar Guru, Prachi Kulkarni & Pankaj Kumar Singh. (2023) Acalabrutinib as a novel hope for the treatment of breast and lung cancer: an in-silico proof of concept. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-16.
Read now
Read now
Nefertiti El-Nikhely, Leyre Larzabal, Werner Seeger, Alfonso Calvo & Rajkumar Savai. (2012) Tumor–stromal interactions in lung cancer: novel candidate targets for therapeutic intervention. Expert Opinion on Investigational Drugs 21:8, pages 1107-1122.
Read now
Read now
Constantin A Dasanu, Nishant Sethi & Nausheen Ahmed. (2012) Immune alterations and emerging immunotherapeutic approaches in lung cancer. Expert Opinion on Biological Therapy 12:7, pages 923-937.
Read now
Read now
Articles from other publishers (71)
Marie Drosslerova, Martina Sterclova, Alice Taskova, Vladislav Hytych, Eva Richterova, Magdalena Bruzova, Miloslav Spunda, Martin Komarc & Martina Koziar Vasakova. (2023) CCL2, CCL8, CXCL12 chemokines in resectable non-small cell lung cancer (NSCLC). Biomedical Papers 167:4, pages 335-339.
Crossref
Crossref
Seyed Ali Mirshahvalad, Reyhaneh Manafi-Farid, Babak Fallahi, Sharareh Seifi, Parham Geramifar, Alireza Emami-Ardekani, Mohammad Eftekhari & Davood Beiki. (2023) Diagnostic value of [68Ga]Ga-Pentixafor versus [18F]FDG PET/CTs in non-small cell lung cancer: a head-to-head comparative study. Nuclear Medicine Communications 44:9, pages 803-809.
Crossref
Crossref
Shunshun Bao, Mohammad Darvishi, Ali H Amin, Maysoon T. Al-Haideri, Indrajit Patra, Khadisha Kashikova, Irfan Ahmad, Fahad Alsaikhan, Zahraa Haleem Al-qaim, Moaed E. Al-Gazally, Bahman Abedi Kiasari, Bahareh Tavakoli-Far, Akmal A. Sidikov, Yasser Fakri Mustafa & Reza Akhavan-Sigari. (2023) CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment. Journal of Cancer Research and Clinical Oncology 149:10, pages 7945-7968.
Crossref
Crossref
Lia Costa, Emília Sousa & Carla Fernandes. (2023) Cyclic Peptides in Pipeline: What Future for These Great Molecules?. Pharmaceuticals 16:7, pages 996.
Crossref
Crossref
Charlise Basson, June Cheptoo Serem, Priyesh Bipath & Yvette Nkondo Hlophe. (2023) Chemokines as possible therapeutic targets in metastatic melanoma. Cancer Medicine 12:13, pages 14387-14402.
Crossref
Crossref
Zhenying Chen, Qianqian Xue & Shaobo Yao. (2023) Nuclear Medicine Application of Pentixafor/Pentixather Targeting CXCR4
for Imaging and Therapy in Related Disease. Mini-Reviews in Medicinal Chemistry 23:7, pages 787-803.
Crossref
Crossref
Ankit Watts, Baljinder Singh, Harmandeep Singh, Amanjit Bal, Harneet Kaur, Ninjit Dhanota, Sunil K. Arora, Bhagwant R. Mittal & Digambar Behera. (2022) [68Ga]Ga-Pentixafor PET/CT imaging for in vivo CXCR4 receptor mapping in different lung cancer histologic sub-types: correlation with quantitative receptors’ density by immunochemistry techniques. European Journal of Nuclear Medicine and Molecular Imaging 50:4, pages 1216-1227.
Crossref
Crossref
Yurie Kogue, Hiroyasu Kobayashi, Yutaka Nakamura, Takatsugu Takano, Chihiro Furuta, Osamu Kawano, Taro Yasuma, Tadashi Nishimura, Corina N. D’Alessandro-Gabazza, Hajime Fujimoto, Esteban C. Gabazza, Tetsu Kobayashi & Ichiro Fukai. (2023) Prognostic Value of CXCL12 in Non-Small Cell Lung Cancer Patients Undergoing Tumor Resection. Pharmaceuticals 16:2, pages 255.
Crossref
Crossref
Saumya Srivastava, Atish Mohanty, Arin Nam, Sharad Singhal & Ravi Salgia. (2022) Chemokines and NSCLC: Emerging role in prognosis, heterogeneity, and therapeutics. Seminars in Cancer Biology 86, pages 233-246.
Crossref
Crossref
Manuela Leo & Lina Sabatino. (2022) Targeting CXCR4 and CD47 Receptors: An Overview of New and Old Molecules for a Biological Personalized Anticancer Therapy. International Journal of Molecular Sciences 23:20, pages 12499.
Crossref
Crossref
Danielle Sandra Nkandeu, Charlize Basson, Anna Margaretha Joubert, June Cheptoo Serem, Priyesh Bipath, Trevor Nyakudya & Yvette Hlophe. (2022) The involvement of a chemokine receptor antagonist CTCE‐9908 and kynurenine metabolites in cancer development. Cell Biochemistry and Function 40:6, pages 608-622.
Crossref
Crossref
Ruogang Zhao, Jianhao Liu, Zhaohuan Li, Wenhui Zhang, Feng Wang & Bo Zhang. (2022) Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy. Pharmaceutics 14:8, pages 1541.
Crossref
Crossref
Baichun Xing, Linlin Yang & Yanan Cui. (2022) Lidocaine inhibited migration of NSCLCA549 cells via the CXCR4 regulation. Cancer Biomarkers 33:3, pages 317-330.
Crossref
Crossref
Wojciech G. Lesniak, Babak Behnam Azad, Samit Chatterjee, Ala Lisok & Martin G. Pomper. (2022) An Evaluation of CXCR4 Targeting with PAMAM Dendrimer Conjugates for Oncologic Applications. Pharmaceutics 14:3, pages 655.
Crossref
Crossref
Xupeng Chai, Eloy Yinwang, Zenan Wang, Zhan Wang, Yucheng Xue, Binghao Li, Hao Zhou, Wenkan Zhang, Shengdong Wang, Yongxing Zhang, Hengyuan Li, Haochen Mou, Lingling Sun, Hao Qu, Fangqian Wang, Zengjie Zhang, Tao Chen & Zhaoming Ye. (2021) Predictive and Prognostic Biomarkers for Lung Cancer Bone Metastasis and Their Therapeutic Value. Frontiers in Oncology 11.
Crossref
Crossref
Dehong Cao, Xiaokaiti Naiyila, Jinze Li, Yin Huang, Zeyu Chen, Bo Chen, Jin Li, Jianbing Guo, Qiang Dong, Jianzhong Ai, Lu Yang, Liangren Liu & Qiang Wei. (2021) Potential Strategies to Improve the Effectiveness of Drug Therapy by Changing Factors Related to Tumor Microenvironment. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Charles M. Rudin, Elisabeth Brambilla, Corinne Faivre-Finn & Julien Sage. (2021) Small-cell lung cancer. Nature Reviews Disease Primers 7:1.
Crossref
Crossref
Zhi-Yong Gao, Liang-Liang Yu, Ben-Xia Shi, Zhen-Ling Dong, Yu-Jie Sun & Hou-Sheng Ma. (2020) T140 Inhibits Apoptosis and Promotes Proliferation and Matrix Formation Through the SDF-1/CXC Receptor-4 Signaling Pathway in Endplate Chondrocytes of the Rat Intervertebral Discs. World Neurosurgery 133, pages e165-e172.
Crossref
Crossref
Chiara Verdelli, Valentina Vaira & Sabrina Corbetta. 2020. Tumor Microenvironments in Organs. Tumor Microenvironments in Organs
37
50
.
Yang Xun, Hua Yang, Jiekai Li, Fuling Wu & Fang Liu. 2020. Reviews of Physiology, Biochemistry and Pharmacology. Reviews of Physiology, Biochemistry and Pharmacology
1
40
.
Di Jia, Yanlin Li, Rui Han, Kun Wang, Guofeng Cai, Chuan He & Lingjian Yang. (2019) miR‑146a‑5p expression is upregulated by the CXCR4 antagonist TN14003 and attenuates SDF‑1‑induced cartilage degradation. Molecular Medicine Reports.
Crossref
Crossref
Maxwell M. Sakyiamah, Takuya Kobayakawa, Masayuki Fujino, Makoto Konno, Tetsuo Narumi, Tomohiro Tanaka, Wataru Nomura, Naoki Yamamoto, Tsutomu Murakami & Hirokazu Tamamura. (2019) Design, synthesis and biological evaluation of low molecular weight CXCR4 ligands. Bioorganic & Medicinal Chemistry 27:6, pages 1130-1138.
Crossref
Crossref
Maria José Costa, Jyothirmayee Kudaravalli, Jing-Tyan Ma, Wei-Hsien Ho, Kathy Delaria, Charles Holz, Angela Stauffer, Allison Given Chunyk, Qing Zong, Eileen Blasi, Bernard Buetow, Thomas-Toan Tran, Kevin Lindquist, Magdalena Dorywalska, Arvind Rajpal, David L. Shelton, Pavel Strop & Shu-Hui Liu. (2019) Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates. Scientific Reports 9:1.
Crossref
Crossref
Ori Wald. (2018) CXCR4 Based Therapeutics for Non-Small Cell Lung Cancer (NSCLC). Journal of Clinical Medicine 7:10, pages 303.
Crossref
Crossref
Magali Lecavalier-Barsoum, Naz Chaudary, Kathy Han, Marianne Koritzinsky, Richard Hill & Michael Milosevic. (2018) Targeting the CXCL12/CXCR4 pathway and myeloid cells to improve radiation treatment of locally advanced cervical cancer. International Journal of Cancer 143:5, pages 1017-1028.
Crossref
Crossref
Shiri Klein, Michal Abraham, Baruch Bulvik, Elia Dery, Ido D. Weiss, Neta Barashi, Rinat Abramovitch, Hanna Wald, Yaniv Harel, Devorah Olam, Lola Weiss, Katia Beider, Orly Eizenberg, Ori Wald, Eithan Galun, Yaron Pereg & Amnon Peled. (2018) CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a/16-1–Mediated ERK and BCL2/Cyclin D1 Pathways. Cancer Research 78:6, pages 1471-1483.
Crossref
Crossref
Ruimeng Yang, Chong Duan, Liya Yuan, John A. Engelbach, Christina I. Tsien, Scott C. Beeman, Carlos J. Perez-Torres, Xia Ge, Keith M. Rich, Joseph J.H. Ackerman & Joel R. Garbow. (2018) Inhibitors of HIF-1α and CXCR4 Mitigate the Development of Radiation Necrosis in Mouse Brain. International Journal of Radiation Oncology*Biology*Physics 100:4, pages 1016-1025.
Crossref
Crossref
Masakazu Katsura, Fumihiro Shoji, Tatsuro Okamoto, Shinichiro Shimamatsu, Fumihiko Hirai, Gouji Toyokawa, Yosuke Morodomi, Tetsuzo Tagawa, Yoshinao Oda & Yoshihiko Maehara. (2018) Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph-node-positive lung cancer patients. Cancer Science 109:1, pages 154-165.
Crossref
Crossref
Leilei Tao, Guichun Huang, Haizhu Song, Yitian Chen & Longbang Chen. (2017) Cancer associated fibroblasts: An essential role in the tumor microenvironment. Oncology Letters 14:3, pages 2611-2620.
Crossref
Crossref
Annemiek M.E. Walenkamp, Constantin Lapa, Ken Herrmann & Hans-Jürgen Wester. (2017) CXCR4 Ligands: The Next Big Hit?. Journal of Nuclear Medicine 58:Supplement 2, pages 77S-82S.
Crossref
Crossref
Wei-Liang Chen, Ai-Fang Huang, Shih-Ming Huang, Ching-Liang Ho, Yung-Lung Chang & James Yi-Hsin Chan. (2016) CD164 promotes lung tumor-initiating cells with stem cell activity and determines tumor growth and drug resistance via Akt/mTOR signaling. Oncotarget 8:33, pages 54115-54135.
Crossref
Crossref
Lingyan Wang, Bijun Zhu, Miaomiao Zhang & Xiangdong Wang. (2017) Roles of immune microenvironment heterogeneity in therapy-associated biomarkers in lung cancer. Seminars in Cell & Developmental Biology 64, pages 90-97.
Crossref
Crossref
Miodrag Dragoj, Zorica Milosevic, Jasna Bankovic, Nikola Tanic, Milica Pesic & Tijana Stankovic. (2016) Targeting CXCR4 and FAK reverses doxorubicin resistance and suppresses invasion in non-small cell lung carcinoma. Cellular Oncology 40:1, pages 47-62.
Crossref
Crossref
Helmut PopperHelmut Popper. 2017. Pathology of Lung Disease. Pathology of Lung Disease
611
638
.
Zhidong Wang, Jian Sun, Yeqian Feng, Xiaocai Tian, Bin Wang & Yong Zhou. (2016) Oncogenic roles and drug target of CXCR4/CXCL12 axis in lung cancer and cancer stem cell. Tumor Biology 37:7, pages 8515-8528.
Crossref
Crossref
Zeng-hui Cheng, Yu-xin Shi, Min Yuan, Dan Xiong, Jiang-hua Zheng & Zhi-yong Zhang. (2016) Chemokines and their receptors in lung cancer progression and metastasis趋化因子及其受体在肺癌侵袭与转移过程中的作用. Journal of Zhejiang University-SCIENCE B 17:5, pages 342-351.
Crossref
Crossref
Zheng Chen, Albert E. Teo & Nami McCarty. (2016) ROS-Induced CXCR4 Signaling Regulates Mantle Cell Lymphoma (MCL) Cell Survival and Drug Resistance in the Bone Marrow Microenvironment via Autophagy. Clinical Cancer Research 22:1, pages 187-199.
Crossref
Crossref
Na Chen, Xiao Jiang, Juan Wang, Tong Wu, Bin Cheng & Juan Xia. (2015) CXCL12-CXCR4/CXCR7 axis contributes to cell motilities of oral squamous cell carcinoma. Tumor Biology 37:1, pages 567-575.
Crossref
Crossref
YAN LIU, BING-QUAN WU, HUA GENG, MEI-LIN XU & HAO-HAO ZHONG. (2015) Association of chemokine and chemokine receptor expression with the invasion and metastasis of lung carcinoma. Oncology Letters 10:3, pages 1315-1322.
Crossref
Crossref
Dietmar W. Siemann & Michael R. Horsman. (2015) Modulation of the tumor vasculature and oxygenation to improve therapy. Pharmacology & Therapeutics 153, pages 107-124.
Crossref
Crossref
Qian Liu, Zhanzhuo Li, Ji-Liang Gao, Wuzhou Wan, Sundar Ganesan, David H. McDermott & Philip M. Murphy. (2015) CXCR4 antagonist AMD3100 redistributes leukocytes from primary immune organs to secondary immune organs, lung, and blood in mice. European Journal of Immunology 45:6, pages 1855-1867.
Crossref
Crossref
Albin Rudisch, Matthew Richard Dewhurst, Luminita Gabriela Horga, Nina Kramer, Nathalie Harrer, Meng Dong, Heiko van der Kuip, Andreas Wernitznig, Andreas Bernthaler, Helmut Dolznig & Wolfgang Sommergruber. (2015) High EMT Signature Score of Invasive Non-Small Cell Lung Cancer (NSCLC) Cells Correlates with NFκB Driven Colony-Stimulating Factor 2 (CSF2/GM-CSF) Secretion by Neighboring Stromal Fibroblasts. PLOS ONE 10:4, pages e0124283.
Crossref
Crossref
Yixiang Mao, Wei Li, Kai Chen, Yufeng Xie, Qiang Liu, Min Yao, Weiming Duan, Xiumin Zhou, Rongrui Liang & Min Tao. (2014) B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer. Oncotarget 6:5, pages 3452-3461.
Crossref
Crossref
C Verdelli, L Avagliano, P Creo, V Guarnieri, A Scillitani, L Vicentini, G B Steffano, E Beretta, L Soldati, E Costa, A Spada, G P Bulfamante & S Corbetta. (2015) Tumour-associated fibroblasts contribute to neoangiogenesis in human parathyroid neoplasia. Endocrine-Related Cancer 22:1, pages 87-98.
Crossref
Crossref
Ido D. Weiss, Ezra Ella, Omri Dominsky, Yoav Smith, Michal Abraham, Hanna Wald, Zippora Shlomai, Gideon Zamir, Sara W. Feigelson, Elias Shezen, Amir Bar-Shai, Ronen Alon, Uzi Izhar, Amnon Peled, Oz M. Shapira & Ori Wald. (2015) In the Hunt for Therapeutic Targets: Mimicking the Growth, Metastasis, and Stromal Associations of Early-Stage Lung Cancer Using a Novel Orthotopic Animal Model. Journal of Thoracic Oncology 10:1, pages 46-58.
Crossref
Crossref
Chuda Chittasupho, Kriengsak Lirdprapamongkol, Prartana Kewsuwan & Narong Sarisuta. (2014) Targeted delivery of doxorubicin to A549 lung cancer cells by CXCR4 antagonist conjugated PLGA nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics 88:2, pages 529-538.
Crossref
Crossref
Blanca D. Lopez‐Ayllon, Veronica Moncho‐Amor, Ander Abarrategi, Inmaculada Ibañez Cáceres, Javier Castro‐Carpeño, Cristobal Belda‐Iniesta, Rosario Perona & Leandro Sastre. (2014) Cancer stem cells and cisplatin‐resistant cells isolated from non‐small‐lung cancer cell lines constitute related cell populations. Cancer Medicine 3:5, pages 1099-1111.
Crossref
Crossref
Ignacio Melero, Gustav Gaudernack, Winald Gerritsen, Christoph Huber, Giorgio Parmiani, Suzy Scholl, Nicholas Thatcher, John Wagstaff, Christoph Zielinski, Ian Faulkner & Håkan Mellstedt. (2014) Therapeutic vaccines for cancer: an overview of clinical trials. Nature Reviews Clinical Oncology 11:9, pages 509-524.
Crossref
Crossref
Matteo Santoni, Sergio Bracarda, Massimo Nabissi, Francesco Massari, Alessandro Conti, Emilio Bria, Giampaolo Tortora, Giorgio Santoni & Stefano Cascinu. (2014) CXC and CC Chemokines as Angiogenic Modulators in Nonhaematological Tumors. BioMed Research International 2014, pages 1-12.
Crossref
Crossref
Francoise Bachelerie, Adit Ben-Baruch, Amanda M. Burkhardt, Christophe Combadiere, Joshua M. Farber, Gerard J. Graham, Richard Horuk, Alexander Hovard Sparre-Ulrich, Massimo Locati, Andrew D. Luster, Alberto Mantovani, Kouji Matsushima, Philip M. Murphy, Robert Nibbs, Hisayuki Nomiyama, Christine A. Power, Amanda E. I. Proudfoot, Mette M. Rosenkilde, Antal Rot, Silvano Sozzani, Marcus Thelen, Osamu Yoshie & Albert Zlotnik. (2014) International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors. Pharmacological Reviews 66:1, pages 1-79.
Crossref
Crossref
Samit Chatterjee, Babak Behnam Azad & Sridhar Nimmagadda. 2014. Emerging Applications of Molecular Imaging to Oncology. Emerging Applications of Molecular Imaging to Oncology
31
82
.
Leyre Larzabal, Nefertiti El-Nikhely, Miriam Redrado, Werner Seeger, Rajkumar Savai & Alfonso Calvo. (2013) Differential Effects of Drugs Targeting Cancer Stem Cell (CSC) and Non-CSC Populations on Lung Primary Tumors and Metastasis. PLoS ONE 8:11, pages e79798.
Crossref
Crossref
Victoria Vinader, Djevdet S. Ahmet, Mohaned S. Ahmed, Laurence H. Patterson & Kamyar Afarinkia. (2013) Discovery and Computer Aided Potency Optimization of a Novel Class of Small Molecule CXCR4 Antagonists. PLoS ONE 8:10, pages e78744.
Crossref
Crossref
STEFAN LANGHAMMER. (2013) Rationale for the design of an oncology trial using a generic targeted therapy multi-drug regimen for NSCLC patients without treatment options (Review). Oncology Reports 30:4, pages 1535-1541.
Crossref
Crossref
Brian J. Morrison, John C. Morris & Jason C. Steel. (2013) Lung cancer-initiating cells: a novel target for cancer therapy. Targeted Oncology 8:3, pages 159-172.
Crossref
Crossref
Kavita S. Subramaniam, Seng Tian Tham, Zahurin Mohamed, Yin Ling Woo, Noor Azmi Mat Adenan & Ivy Chung. (2013) Cancer-Associated Fibroblasts Promote Proliferation of Endometrial Cancer Cells. PLoS ONE 8:7, pages e68923.
Crossref
Crossref
Sharron Vass & Margarete M.S. Heck. (2013) Perturbation of invadolysin disrupts cell migration in zebrafish (Danio rerio). Experimental Cell Research 319:8, pages 1198-1212.
Crossref
Crossref
Sebastiano Cavallaro. (2013) CXCR4/CXCL12 in Non-Small-Cell Lung Cancer Metastasis to the Brain. International Journal of Molecular Sciences 14:1, pages 1713-1727.
Crossref
Crossref
Magdalena Tertil, Klaudia Skrzypek & Agnieszka Łoboda. 2013. Angiogenesis and Vascularisation. Angiogenesis and Vascularisation
367
387
.
Peter M. Clark, Noor Dawany, William Dampier, Stephen W. Byers, Richard G. Pestell & Aydin Tozeren. (2012) Bioinformatics analysis reveals transcriptome and microRNA signatures and drug repositioning targets for IBD and other autoimmune diseases. Inflammatory Bowel Diseases 18:12, pages 2315-2333.
Crossref
Crossref
Duha Fahham, Ido D. Weiss, Michal Abraham, Katia Beider, Wald Hanna, Zippora Shlomai, Orly Eizenberg, Gideon Zamir, Uzi Izhar, Oz M. Shapira, Amnon Peled & Ori Wald. (2012) In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non–small cell lung cancer. The Journal of Thoracic and Cardiovascular Surgery 144:5, pages 1167-1175.e1.
Crossref
Crossref
Yasushi Otani, Takashi Kijima, Satoshi Kohmo, Shinya Oishi, Toshiyuki Minami, Izumi Nagatomo, Ryo Takahashi, Haruhiko Hirata, Mayumi Suzuki, Koji Inoue, Yoshito Takeda, Hiroshi Kida, Isao Tachibana, Nobutaka Fujii & Atsushi Kumanogoh. (2012) Suppression of metastases of small cell lung cancer cells in mice by a peptidic CXCR4 inhibitor TF14016. FEBS Letters 586:20, pages 3639-3644.
Crossref
Crossref
Stefan Kastner, Tilman Voss, Simon Keuerleber, Christina Glöckel, Michael Freissmuth & Wolfgang Sommergruber. (2012) Expression of G Protein-Coupled Receptor 19 in Human Lung Cancer Cells Is Triggered by Entry into S-Phase and Supports G2–M Cell-Cycle Progression. Molecular Cancer Research 10:10, pages 1343-1358.
Crossref
Crossref
Crescenzo D’Alterio, Antonio Barbieri, Luigi Portella, Giuseppe Palma, Marianeve Polimeno, Anna Riccio, Caterina Ieranò, Renato Franco, Giosuè Scognamiglio, Jane Bryce, Antonio Luciano, Domenica Rea, Claudio Arra & Stefania Scala. (2012) Inhibition of stromal CXCR4 impairs development of lung metastases. Cancer Immunology, Immunotherapy 61:10, pages 1713-1720.
Crossref
Crossref
Qian Liu, Haoqian Chen, Teresa Ojode, Xiangxi Gao, Sandra Anaya-O'BrienNicholas A. Turner, Jean UlrickRosamma DeCastroCorin KellyAdela R. Cardones, Stuart H. Gold, Eugene I. Hwang, Daniel S. Wechsler, Harry L. MalechPhilip M. Murphy & David H. McDermott. (2012) WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4. Blood 120:1, pages 181-189.
Crossref
Crossref
Annamaria Rapisarda & Giovanni Melillo. (2012) Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia. Nature Reviews Clinical Oncology 9:7, pages 378-390.
Crossref
Crossref
Victoria Vinader & Kamyar Afarinkia. (2012) The emerging role of CXC chemokines and their receptors in cancer. Future Medicinal Chemistry 4:7, pages 853-867.
Crossref
Crossref
Shinya Oishi & Nobutaka Fujii. (2012) Peptide and peptidomimetic ligands for CXC chemokine receptor 4 (CXCR4). Organic & Biomolecular Chemistry 10:30, pages 5720.
Crossref
Crossref
Joeri Kuil, Tessa Buckle & Fijs W. B. van Leeuwen. (2012) Imaging agents for the chemokine receptor 4 (CXCR4). Chemical Society Reviews 41:15, pages 5239.
Crossref
Crossref
Orit Jacobson, Ido D. Weiss, Lawrence P. Szajek, Gang Niu, Ying Ma, Dale O. Kiesewetter, Amnon Peled, Henry S. Eden, Joshua M. Farber & Xiaoyuan Chen. (2012) Improvement of CXCR4 tracer specificity for PET imaging. Journal of Controlled Release 157:2, pages 216-223.
Crossref
Crossref
Albert Zlotnik, Amanda M. Burkhardt & Bernhard Homey. (2011) Homeostatic chemokine receptors and organ-specific metastasis. Nature Reviews Immunology 11:9, pages 597-606.
Crossref
Crossref